ACNE SPOT TREATMENT
- Product NDC
- 70764-105
- 11-digit product format
- 707640105
- Labeler code
- 70764
- Product ID
- 70764-105_474bb8a5-0d4f-2e4b-e063-6394a90ac399
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- SALICYLIC ACID
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- CONTROL CORRECTIVE SKINCARE INC
- Application
- M006
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-06-09
- Substance
- SALICYLIC ACID
- Active strength
- 2 g/100mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 70764-105-51 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 70764-105-51 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 70764-105-51 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 70764-105-51 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 70764-105-51 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 70764-105-51 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70764-105-51 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70764-105-51 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70764-105-51 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ACNE SPOT TREATMENT
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SALICYLIC ACID | 2 g/100mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| O414PZ4LPZ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 346298 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 11d47f80-02ae-44a6-acf1-3babb762967b | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70764-105-51 | 2025-12-31 | C162847 | 48780-1 | 2cef2736-8a4f-d83d-e063-dadaa90ab31f | CONTROL CORRECTIVE (70764-105) |
| 70764-105-51 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8a4f-d83d-e063-dadaa90ab31f | CONTROL CORRECTIVE (70764-105) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70764-105-11 | ACNE SPOT TREATMENT | 30 mL in 1 BOTTLE | GEL | 30 | 5 | |
| 70764-105-51 | ACNE SPOT TREATMENT | 1 in 1 BOX | GEL | 1 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lancome Paris Clarifique BX-Interceptor Topical Acne Clearing Treatment | SALICYLIC ACID | SICOS ET CIE | 6e366dc4-288a-47b1-ab72-8ed3aa6aea22 | 2026-03-02 | Warnings | M006 |
| Lancome Paris Clarifique BX-Interceptor Topical Acne Clearing Treatment | SALICYLIC ACID | LOreal USA Products Inc | c5ce4ec6-176f-4bb0-96f0-6817e53c1468 | 2026-03-02 | Warnings | M006 |
| FOLUPIA MILIA REMOVER | SALICYLIC ACID 1% MILIA REMOVER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4bca1a8b-2df4-47b1-e063-6394a90a33ff | 2026-02-27 | Warnings | M006 |
| Medicated Apricot Scrub | SALICYLIC ACID | Walmart Inc. | 56e29d46-a29d-4192-9fdf-58dbcb843d44 | 2026-02-27 | Warnings | M006 |
| Acne Treatment | BENZOYL PEROXIDE | Walmart Inc. | 950edb4e-fbba-41e3-9ec5-973806e555e7 | 2026-02-27 | Warnings, Adverse reactions | M006 |
| Body Wash | SALICYLIC ACID | Walmart Inc. | c31a5629-66c3-47a7-96ea-9987b2be82af | 2026-02-27 | Warnings, Adverse reactions | M006 |
| Acne Control Cleanser | SALICYLIC ACID | Walmart Inc. | 2df52d35-dbb6-1d35-e063-6394a90ae110 | 2026-02-27 | Warnings, Adverse reactions | M006 |
| Quick Action | SALICYLIC ACID | Walmart Inc. | 00025ea5-d15f-49d2-a52a-6c1bd8c6a033 | 2026-02-27 | Warnings, Adverse reactions | M006 |
| Oil Free Acne Wash | SALICYLIC ACID 2% | Walmart Inc. | 31e49de0-0806-d18b-e063-6294a90ae47d | 2026-02-27 | Warnings, Adverse reactions | M006 |
| ACNE SOLUTIONS SPOT HEALING ACNE MEDICATION | SALICYLIC ACID | CLINIQUE LABORATORIES LLC | c09ee4f6-b8f9-4d20-982a-fb490830bd34 | 2026-02-26 | Warnings | M006 |
| Acne Treatment | BENZOYL PEROXIDE | The Kroger Co. | a6526d73-4094-45b7-97f0-561dd10d61e2 | 2026-02-26 | Warnings, Adverse reactions | M006 |
| Oil Free Acne Wash | SALICYLIC ACID 2% | Meijer, Inc. | 29a62723-a58d-4912-bdab-b2fa1fac27b4 | 2026-02-24 | Warnings, Adverse reactions | M006 |
| Medicated Apricot Scrub | SALICYLIC ACID | Meijer, Inc. | 3aeb4f0b-a8f7-4ed7-b320-45e5ba0c8175 | 2026-02-19 | Warnings, Adverse reactions | M006 |
| Acne Cleanser | BENZOYL PEROXIDE | Meijer, Inc. | 932ee049-ab3d-4839-a655-772e5594f6e1 | 2026-02-19 | Warnings, Adverse reactions | M006 |
| PHARMA CLEAR SPOT TREATMENT | SALICYLIC ACID | PHARMAGEL INTERNATIONAL INC | 24736409-b500-4aae-857e-1f4fb1760a15 | 2026-02-19 | Warnings | M006 |
| Acne Scrub | SALICYLIC ACID | United Natural Foods, Inc. dba UNFI | 1a4df18d-8128-4846-80bc-262ba1a2aeca | 2026-02-17 | Warnings, Adverse reactions | M006 |
| Oil Free Acne Wash | SALICYLIC ACID 2% | United Natural Foods, Inc. dba UNFI | c489c818-d69a-4011-9c37-60c8c5b9522a | 2026-02-17 | Warnings, Adverse reactions | M006 |
| Medicated Apricot Scrub | SALICYLIC ACID | United Natural Foods, Inc. dba UNFI | 677c19eb-780b-479b-ab1d-df249e0af6ea | 2026-02-16 | Warnings, Adverse reactions | M006 |
| PoreFect | SALICYLIC ACID | Our-Science Inc. | 4afe4115-cdf0-6dd3-e063-6394a90a2453 | 2026-02-16 | Warnings | M006 |
| iShancare Folliculitis Cream | FOLLICULITIS CREAM | Shenzhen Ishan Technology Co., Ltd | 0c85c8e9-f50f-1b72-e063-6394a90a88c4 | 2026-02-13 | Warnings | M006 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 346298 | salicylic acid 2 % Topical Gel | PSN | 11d47f80-02ae-44a6-acf1-3babb762967b | 5 |
| 346298 | salicylic acid 0.02 MG/MG Topical Gel | SCD | 11d47f80-02ae-44a6-acf1-3babb762967b | 5 |
| 346298 | salicylic acid 2 % Topical Gel | SY | 11d47f80-02ae-44a6-acf1-3babb762967b | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70764-105-11 | 70764010511 | 30 mL in 1 BOTTLE | 30 ml | Historical | ||||
| 70764-105-51 | 70764010551 | 1 BOTTLE in 1 BOX (70764-105-51) / 30 mL in 1 BOTTLE (70764-105-11) | 1 bottle | 2016-06-09 | 0000-00-00 | No | No | Current |